As of close of business last night, Aurora Cannabis Inc’s stock clocked out at $4.31, down -1.82% from its previous closing price of $4.39. In other words, the price has decreased by -$0.0800 from its previous closing price. On the day, 3919853 shares were traded.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Ratios:
To gain a deeper understanding of ACB’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.45 and its Current Ratio is at 3.79. In the meantime, Its Debt-to-Equity ratio is 0.20 whereas as Long-Term Debt/Eq ratio is at 0.15.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ACB now has a Market Capitalization of 234.32M and an Enterprise Value of 200.89M. As of this moment, Aurora’s Price-to-Earnings (P/E) ratio for their current fiscal year is 0.48. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.33 while its Price-to-Book (P/B) ratio in mrq is 0.52. Its current Enterprise Value per Revenue stands at 0.95 whereas that against EBITDA is -0.12.
Stock Price History:
Over the past 52 weeks, ACB has reached a high of $11.50, while it has fallen to a 52-week low of $2.84. The 50-Day Moving Average of the stock is 3.7048, while the 200-Day Moving Average is calculated to be 4.8481.
Shares Statistics:
It appears that ACB traded 1.82M shares on average per day over the past three months and 7.02M shares per day over the past ten days. A total of 34.53M shares are outstanding, with a floating share count of 15.49M. Insiders hold about 1.50% of the company’s shares, while institutions hold 30.36% stake in the company. Shares short for ACB as of Mar 15, 2024 were 3.82M with a Short Ratio of 2.10, compared to 3.55M on Feb 15, 2024.
Earnings Estimates
As of right now, 2 analysts gave their recommendation on the stock of the company. On average, analysts expect EPS of -$0.17 for the current quarter, with a high estimate of -$0.04 and a low estimate of -$0.3, while EPS last year was -$1.48. The consensus estimate for the next quarter is -$0.2, with high estimates of -$0.2 and low estimates of -$0.2.
Analysts are recommending an EPS of between -$0.07 and -$1.63 for the fiscal current year, implying an average EPS of -$0.93. EPS for the following year is -$0.32, with 3 analysts recommending between -$0.07 and -$0.73.
Revenue Estimates
In the current quarter, 4 analysts expect revenue to total $51.89M. It ranges from a high estimate of $53.9M to a low estimate of $51.07M. As of the current estimate, Aurora Cannabis Inc’s year-ago sales were $46.86M, an estimated increase of 10.70% from the year-ago figure.
Based on 4 analysts’ estimates, the company’s revenue will be $237.05M in the next fiscal year. The high estimate is $250.15M and the low estimate is $224.76M. The average revenue growth estimate for next year is up 17.30% from the average revenue estimate for this year.
